Eisai Co., Ltd.
ESALFOTCHealthcare● Active
$23.88
+$0.00(+0.00%)
Market Cap$6.7B
P/E Ratio—
52W High$35.83
52W Low$23.88
Eisai Co., Ltd.（ESALF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ESALF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $38.80B | $61.06B | $42.41B | $55.43B | $47.95B |
| Depreciation & Amort. | $39.80B | $39.91B | $39.40B | $39.98B | $38.40B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($21.48B) | ($47.38B) | ($46.47B) | ($69.25B) | $34.13B |
| Net Cash from Operations | $61.71B | $30.12B | $55.99B | ($1.77B) | $117.59B |
| Investing Activities | |||||
| Capital Expenditure | ($15.46B) | ($22.97B) | ($24.82B) | ($34.56B) | ($40.47B) |
| Purchases of Investments | ($3.09B) | ($4.41B) | ($6.50B) | ($3.70B) | ($3.13B) |
| Sales of Investments | $13.71B | $2.81B | $3.88B | $10.22B | $2.49B |
| Net Cash from Investing | ($42.06B) | ($10.10B) | ($25.32B) | ($22.72B) | ($28.85B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.01B) | ($30.11B) | ($0.02B) | $0.00B | $0.00B |
| Dividends Paid | ($45.42B) | ($45.55B) | ($45.91B) | ($45.89B) | ($45.88B) |
| Debt Issued / Repaid | ($4.45B) | $28.29B | $33.26B | $31.17B | $4.87B |
| Net Cash from Financing | ($61.48B) | ($57.81B) | ($22.72B) | ($24.52B) | ($48.97B) |
| Free Cash Flow | |||||
| Free Cash Flow | $46.25B | $7.15B | $31.17B | ($36.33B) | $77.12B |
| FCF Margin %(computed) | 5.57% | 0.91% | 4.20% | -4.88% | 10.20% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · JPY · B
深入了解Eisai Co., Ltd.
关于Eisai Co., Ltd.（ESALF）现金流量表
Eisai Co., Ltd. 2026财年经营活动现金流$61.71B，自由现金流$46.25B（FCF利润率5.57%），资本支出($15.46B)。
常见问题
ESALF · 4 问Eisai Co., Ltd. 2026财年自由现金流$46.25B，同比up547.1%。
ESALF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10